✦ LIBER ✦

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout

✍ Scribed by Ming-Han H. Lee, Garry G. Graham, Kenneth M. Williams, Dr Richard O. Day

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Assessment of Zaleplon in t

✍ Dr Joseph Barbera, Colin Shapiro 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 139 KB

Benefit-Risk Assessment of Rofecoxib in

✍ Helmut Schmidt, Barry G. Woodcock, Professor Dr Gerd Geisslinger 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 137 KB

A Benefit-Risk Assessment of Agomelatine

✍ Robert H. Howland MD 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 229 KB

A Benefit-Risk Assessment of Dapoxetine

✍ Kate Hutchinson, Kelly Cruickshank, Professor Kevan Wylie 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 183 KB

A Risk-Benefit Assessment of Sildenafil

✍ Dr Dinko Vitezic 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 155 KB

A Risk-Benefit Assessment of Alendronate

✍ Dr Jean-Pierre Devogelaer 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 177 KB